Considerations in insulin delivery device selection

Diabetes Technology and Therapeutics

Volumn 12, Issue SUPPL. 1, 2010, Pages

  Valentine, Virginia ^a   Kruger, Davida F ^b  

^a Diabetes Network Inc   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO;

ACCURACY; BLOOD GLUCOSE MONITORING; DIABETES MELLITUS; DISPOSABLE EQUIPMENT; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERMETHOD COMPARISON; MARKETING; NEEDLE; PATIENT ATTITUDE; PATIENT SAFETY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROFESSIONAL KNOWLEDGE; RECYCLING; SHORT SURVEY; VISUAL IMPAIRMENT;

CHOICE BEHAVIOR; DIABETES MELLITUS, TYPE 2; DISPOSABLE EQUIPMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; EUROPE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MARKETING; NEEDLES; UNITED STATES;

EID: 77956137703     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0007     Document Type: Short Survey

References (6)

1. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B; American Diabetes Association; European Association for Study of Diabetes: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
2. Polonsky WH, Villa-Caballero L, Fisher L, Villa-Caballero L, Edelman SV: Psychological insulin resistance in patients with type 2 diabetes. Diabetes Care 2005;28:2543-2545.
3. Rubin RR, Peyrot M: Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-432.
4. Ignaut DA, Schwartz SL, Sarwat S, Murphy HL: Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen. Diabetes Educ 2009;35:789-798.
5. Lane WS, Cochran EK, Jackson JA, Scism-Bacon JL, Corey IB, Hirsch IB, Skyler JS: High dose insulin therapy: is it time for U-500 insulin? Endocr Pract 2009;15:71-79.
6. Kreugel G, Keers JC, Jongbloed A, Verweij-Gjaltema AH, Wlffenbuttel BHR: The influence of needle length on glycemic control and patient preference in obese diabetic patients. Diabetes 2009;58(Suppl 1):440-P.